Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Also known as Colesevelam hydrochloride film-coated tablets (Cholestagel)
Colesevelam film-coated · 1 trial · 1 indication
| Name | Type | Description |
|---|---|---|
| Colesevelam hydrochloride film-coated tablets (Cholestagel) | DRUG | - |
Inclusion Criteria: * Subject must have a body mass index (BMI) between 19 and 25 inclusive * Medically healthy subjects with clinically normal laboratory profiles, physical exams, vital signs and ECGs. * Give voluntary written informed consent to participate in the study Exclusion Criteria: * Hi...
Colesevelam film-coated is a film-coated tablet formulation of colesevelam hydrochloride, also known as Cholestagel. It is a small molecule developed by Sanofi (ticker SNY). The specific indication for this film-coated presentation is undisclosed, and it has been studied in a Phase 1 trial in healthy volunteers.
Colesevelam film-coated is made by Sanofi, which trades under the ticker SNY. Sanofi is the developer of the colesevelam hydrochloride film-coated tablets also known as Cholestagel.
Colesevelam film-coated is in Phase 1 development. One Phase 1 trial has been completed, and no active trials are ongoing. It is an investigational formulation and is not approved for any indication based on the available development data.
Colesevelam film-coated has been evaluated in one completed Phase 1 trial, NCT00692250, titled A Study to Assess Any Potential Interaction Between Colesevelam and Ciclosporin in Healthy Volunteers. The trial enrolled 14 healthy male volunteers in the Netherlands and was randomized but uncontrolled.
Yes, Colesevelam film-coated is also known as colesevelam hydrochloride film-coated tablets (Cholestagel). Cholestagel is the brand name for this film-coated formulation developed by Sanofi.